WHO recommends antibody treatment for high-risk COVID-19 patients |
Clinical News
eMediNexus Coverage from: 
WHO recommends antibody treatment for high-risk COVID-19 patients

0 Read Comments                

The World Health Organization (WHO) has recommended the use of Regeneron synthetic antibody treatment for COVID-19 in patients with some specific health profiles.Individuals who have non-severe COVID-19 and are still at high risk of hospitalization can be given the antibody combination. It can also be administered to severely ill patients who are not able to mount an adequate immune response. The findings are published in the BMJ.Regeneron is a combination of synthetic antibodies casirivimab and...
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now